These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23530117)
1. Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey. Dagres N; Lewalter T; Lip GY; Pison L; Proclemer A; Blomström-Lundqvist C; Europace; 2013 Apr; 15(4):478-81. PubMed ID: 23530117 [TBL] [Abstract][Full Text] [Related]
2. Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF. Chiang CE; Goethals M; O'Neill JO; Naditch-Brûlé L; Brette S; Gamra H; Zharinov O; Steg PG; Europace; 2013 Dec; 15(12):1733-40. PubMed ID: 23858023 [TBL] [Abstract][Full Text] [Related]
3. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Gillis AM; Verma A; Talajic M; Nattel S; Dorian P; Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862 [TBL] [Abstract][Full Text] [Related]
4. Work-up and management of lone atrial fibrillation: results of the European Heart Rhythm Association Survey. Pison L; Hocini M; Potpara TS; Todd D; Chen J; Blomström-Lundqvist C; Europace; 2014 Oct; 16(10):1521-3. PubMed ID: 25267359 [TBL] [Abstract][Full Text] [Related]
5. Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. Dobreanu D; Svendsen JH; Lewalter T; Hernández-Madrid A; Lip GY; Blomström-Lundqvist C; Europace; 2013 Aug; 15(8):1223-5. PubMed ID: 23878150 [TBL] [Abstract][Full Text] [Related]
6. Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey. Hernández-Madrid A; Svendsen JH; Lip GY; Van Gelder IC; Dobreanu D; Blomstrom-Lundqvist C; Europace; 2013 Jun; 15(6):915-8. PubMed ID: 23709570 [TBL] [Abstract][Full Text] [Related]
7. Current strategy for treatment of patients with Wolff-Parkinson-White syndrome and asymptomatic preexcitation in Europe: European Heart Rhythm Association survey. Svendsen JH; Dagres N; Dobreanu D; Bongiorni MG; Marinskis G; Blomström-Lundqvist C; Europace; 2013 May; 15(5):750-3. PubMed ID: 23625944 [TBL] [Abstract][Full Text] [Related]
8. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881 [TBL] [Abstract][Full Text] [Related]
9. Dronedarone: an emerging agent with rhythm- and rate-controlling effects. Wegener FT; Ehrlich JR; Hohnloser SH J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434 [TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey. Berisso MZ; Fabbri G; Gonzini L; Caruso D; Fontanella A; Pellegrini F; Silvestri N; Vincenti A; Mathieu G; Di Pasquale G; J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):626-35. PubMed ID: 24978662 [TBL] [Abstract][Full Text] [Related]
11. Dronedarone: an emerging therapy for atrial fibrillation. Rosei EA; Salvetti M Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270 [TBL] [Abstract][Full Text] [Related]
12. Dronedarone: an overview. Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation. Kosior D; Opolski G; Torbicki A Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496 [TBL] [Abstract][Full Text] [Related]
14. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations. Singh BN J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):31S-5S. PubMed ID: 21098417 [TBL] [Abstract][Full Text] [Related]
15. Comparing the 2010 North American and European atrial fibrillation guidelines. Gillis AM; Skanes AC Can J Cardiol; 2011; 27(1):7-13. PubMed ID: 21329856 [TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation. Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S J Cardiol; 2016 May; 67(5):471-6. PubMed ID: 26233885 [TBL] [Abstract][Full Text] [Related]